diagnostics with Klarite
Klarite offers the potential to deliver an extremely sensitive in-vitro
diagnostic test from bodily fluid samples - with little or no sample
preparation - producing almost instant results which are ideal for
the point of care environment.
The technique delivers a unique trace of the molecule fingerprint
of a sample in only a few seconds. This fingerprint can be used to
identify one or more chemical compounds that are known biomarkers
indicating presence of a disease. Alternatively, the technique can
show complex changes in the chemical balance of a patient that may
be characteristic of a particular disease, even if the indicator chemicals
Researchers worldwide, including groups at University Michigan in
the USA, have already demonstrated the potential of this technique
to work with real life samples and produce clinically relevant results
for early stage osteoarthritis detection.
Other groups including Gloucester Royal Hospital in the United Kingdom
are looking at the differentiation of viral and bacterial eye infections,
whilst others are looking for early indicators of heart disease.
In all cases, Klarite offers the potential for near instantaneous
very early stage diagnosis - often before presentation of physical
symptoms. Early treatment has a much better prognosis for the patient,
sometimes enabling treatment before disease impact becomes irreversible.
In addition this diagnosis offers significant cost savings to health
provides by reducing the risk of incorrect diagnosis, avoiding the
potential for both in-patient care and the long term provision of
symptom relieving drugs with the omnipresent danger of unforeseen